Bill & Melinda Gates FoundationGlobal Grand Challenges
  • Grant Opportunities
  • Challenges
  • Awards
  • Champions
  • Partnerships
  • News
  • About

Nanoparticle Platform for TB Vaccine Targeting Lymph Nodes

Melody Swartz and Jeffrey Hubbell of the Ecole Polytechnique Fédérale de Lausanne (EPFL), Switzerland, will explore the use of a robust and inexpensive nanotechnology, which may penetrate lymph tissue to more effectively trigger immune responses, as a new tool for prevention of TB.

More information about Create New Vaccines for Diarrhea, HIV, Malaria, Pneumonia, and Tuberculosis (Round 2)